Breaking News Instant updates and real-time market news.

SRNE

Sorrento Therapeutics

$2.27

-0.01 (-0.44%)

07:23
09/23/19
09/23
07:23
09/23/19
07:23

Scilex announces confidential submission of draft registration statement for IPO

Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, announced that it has confidentially submitted a draft registration statement on Form S-1 to the U.S. Securities and Exchange Commission relating to its proposed initial public offering of its common stock. The size and price range for the proposed offering have not yet been determined. The initial public offering is expected to commence after the completion of the SEC review process, subject to market and other conditions.

SRNE Sorrento Therapeutics
$2.27

-0.01 (-0.44%)

12/12/18
HCWC
12/12/18
NO CHANGE
HCWC
Buy
Sorrento Therapeutics has multiple catalysts in 2019, says H.C. Wainwright
2019 should represent a turning point for Sorrento Therapeutics, H.C. Wainwright analyst Raghuram Selvaraju tells investors in a research note. The analyst believes the company is in position to report "multiple value-driving clinical data catalysts" over the course of 2019, both with its pain management portfolio and its cancer immunotherapy candidates. He thinks the interest in anti-CD38 CAR-T approaches has only increased following the recently concluded American Society for Hematology annual meeting. Further, Sorrento's recent financing transactions "provide a pathway to sustainability," adds Selvaraju. He reiterates a Buy rating on the shares with a $40 price target.
03/20/19
RILY
03/20/19
NO CHANGE
Target $12
RILY
Buy
B. Riley FBR boosts Sorrento target to $12, sees 'numerous' catalysts
B. Riley FBR analyst Andrew D'Silva raised his price target for Sorrento Therapeutics to $12.00 from $10.50 and maintains a Buy rating on the shares following the company's Q4 results. Following the "strong close to 2018," the analyst lowered his cash burn estimates and pushed out projected capital raises. The top- and bottom-line beats were due to higher sales and services revenue, primarily out of Scilex Pharmaceuticals, the company's majority-owned subsidiary, as ZTlido sales were recognized a quarter earlier than expected, D'Silva tells investors in a research note. The analyst, however, continues to believe the primary driving force of Sorrento's share price is "locked in its product pipeline." With "numerous high-value opportunities" that primarily extend across immuno-oncology, pain management, and animal health, D'Silva sees a positive risk/reward on the stock.
07/23/19
HCWC
07/23/19
NO CHANGE
Target $30
HCWC
Buy
Sorrento Therapeutics price target lowered to $30 from $40 at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju lowered his price target for Sorrento Therapeutics to $30 from $40 to reflect dilution from the company's sale of 8.3M shares at $3.00. He views resiniferatoxin as one of the most promising projects in Sorrento's pipeline and reiterates a Buy rating on the shares, however.

TODAY'S FREE FLY STORIES

10:19
11/20/19
11/20
10:19
11/20/19
10:19
Conference/Events
UBS leisure/travel analyst to hold an analyst/industry conference call »

Leisure, Gaming &…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
11/20/19
11/20
10:17
11/20/19
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
11/20/19
11/20
10:16
11/20/19
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JWN

Nordstrom

$34.28

-1.23 (-3.46%)

10:15
11/20/19
11/20
10:15
11/20/19
10:15
Options
Nordstrom put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

  • 05

    Dec

10:15
11/20/19
11/20
10:15
11/20/19
10:15
General news
Breaking General news story  »

Week of 11/15 EIA…

JNJ

Johnson & Johnson

$134.64

-0.17 (-0.13%)

, BCO

Brink's

$90.38

0.345 (0.38%)

10:11
11/20/19
11/20
10:11
11/20/19
10:11
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

JNJ

Johnson & Johnson

$134.64

-0.17 (-0.13%)

BCO

Brink's

$90.38

0.345 (0.38%)

KLAC

KLA-Tencor

$176.76

0.72 (0.41%)

NEX

NexTier Oilfield

$4.47

-0.2 (-4.28%)

TAST

Carrols Restaurant

$7.63

0.24 (3.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

  • 07

    Dec

  • 09

    Dec

  • 21

    Jan

BRY

Berry Petroleum

$7.20

-1.7 (-19.10%)

, KSS

Kohl's

$46.75

-0.26 (-0.55%)

10:11
11/20/19
11/20
10:11
11/20/19
10:11
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

BRY

Berry Petroleum

$7.20

-1.7 (-19.10%)

KSS

Kohl's

$46.75

-0.26 (-0.55%)

WWD

Woodward

$114.24

-1.59 (-1.37%)

SHW

Sherwin-Williams

$581.49

-2.99 (-0.51%)

CSLT

Castlight Health

$1.38

-0.045 (-3.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

CGC

Canopy Growth

$17.12

1.8 (11.75%)

, SLB

Schlumberger

$34.35

0.04 (0.12%)

10:10
11/20/19
11/20
10:10
11/20/19
10:10
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

CGC

Canopy Growth

$17.12

1.8 (11.75%)

SLB

Schlumberger

$34.35

0.04 (0.12%)

I

Intelsat

$6.93

0.85 (13.98%)

PAYC

Paycom

$251.90

12.1 (5.05%)

TW

Tradeweb Markets

$44.45

1.19 (2.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

  • 10

    Dec

10:08
11/20/19
11/20
10:08
11/20/19
10:08
Conference/Events
UBS services/restaurants analysts to hold analyst/industry conference call »

Services Analyst…

CBS

CBS

$39.15

-0.25 (-0.63%)

10:05
11/20/19
11/20
10:05
11/20/19
10:05
Options
CBS call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HUM

Humana

$334.94

-1.25 (-0.37%)

10:04
11/20/19
11/20
10:04
11/20/19
10:04
Hot Stocks
Humana, agilon health announce value-based care agreements »

Humana announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

PLT

Poly

$25.23

-0.54 (-2.10%)

10:03
11/20/19
11/20
10:03
11/20/19
10:03
Hot Stocks
Breaking Hot Stocks news story on Poly »

Poly drops 3% to $25.02…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

MIST

Milestone Pharmaceuticals

$17.10

-0.46 (-2.62%)

10:02
11/20/19
11/20
10:02
11/20/19
10:02
Syndicate
Milestone Pharmaceuticals 750K share Block Trade priced at $16.00 »

Jefferies acted as sole…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

PLUG

Plug Power

$3.42

0.03 (0.88%)

10:01
11/20/19
11/20
10:01
11/20/19
10:01
Conference/Events
Plug Power management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

PLT

Poly

$25.23

-0.54 (-2.10%)

10:00
11/20/19
11/20
10:00
11/20/19
10:00
Hot Stocks
Poly expects to maintain annual dividend of 60c per share »

Poly in investor day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

LOW

Lowe's

$120.46

7.05 (6.22%)

10:00
11/20/19
11/20
10:00
11/20/19
10:00
Hot Stocks
Lowe's says expects FY19 adjusted operating margin up 40-60 basis points »

Sees FY19: Cash flow of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Dec

PJC

Piper Jaffray

$78.87

(0.00%)

09:59
11/20/19
11/20
09:59
11/20/19
09:59
Conference/Events
Piper Jaffray management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 22

    Nov

PLT

Poly

$25.15

-0.62 (-2.41%)

09:58
11/20/19
11/20
09:58
11/20/19
09:58
Earnings
Poly sees fiscal 2021 adjusted EBITDA improved from fiscal 2020 »

Poly in investor day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

MTZ

MasTec

$68.50

-2.51 (-3.53%)

09:57
11/20/19
11/20
09:57
11/20/19
09:57
Syndicate
MasTec 2.8M share Block Trade priced at $69.00 »

The deal range was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

MOBL

MobileIron

$4.79

0.03 (0.63%)

09:57
11/20/19
11/20
09:57
11/20/19
09:57
Conference/Events
MobileIron management to meet with Craig-Hallum »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

PLT

Poly

$25.24

-0.53 (-2.06%)

09:56
11/20/19
11/20
09:56
11/20/19
09:56
Earnings
Poly affirms Q3, fiscal 2020 guidance at investor day »

Poly in investor day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

LTHM

Livent

$7.47

-0.15 (-1.97%)

09:55
11/20/19
11/20
09:55
11/20/19
09:55
Conference/Events
Livent management to meet with Loop Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

  • 22

    Nov

  • 05

    Dec

  • 06

    Dec

TGT

Target

$120.00

9.14 (8.24%)

, LOW

Lowe's

$120.40

6.99 (6.16%)

09:55
11/20/19
11/20
09:55
11/20/19
09:55
Options
Early notable gainers among liquid option names on November 20th »

Notable gainers among…

TGT

Target

$120.00

9.14 (8.24%)

LOW

Lowe's

$120.40

6.99 (6.16%)

HOLX

Hologic

$48.53

1.36 (2.88%)

HSY

Hershey

$149.40

1.78 (1.21%)

DG

Dollar General

$160.16

1.69 (1.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 20

    Nov

  • 03

    Dec

  • 05

    Dec

  • 09

    Dec

SFTBF

SoftBank

$0.00

(0.00%)

, SFTBY

SoftBank

$0.00

(0.00%)

09:53
11/20/19
11/20
09:53
11/20/19
09:53
Periodicals
SoftBank in talks for financing to fund WeWork turnaround, Nikkei reports »

SoftBank (SFTBF) is in…

SFTBF

SoftBank

$0.00

(0.00%)

SFTBY

SoftBank

$0.00

(0.00%)

WE

We Company

$0.00

(0.00%)

MTU

Mitsubishi UFJ

$0.00

(0.00%)

SMFG

Sumitomo Mitsui

$7.26

-0.06 (-0.82%)

MFG

Mizuho Financial Group

$3.13

-0.01 (-0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

LRCX

Lam Research

$276.52

-0.12 (-0.04%)

09:53
11/20/19
11/20
09:53
11/20/19
09:53
Conference/Events
Lam Research management to meet with KeyBanc »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

  • 22

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.